Skip to content

Investigating the effect of team cooperation in the administration of normal labor and delivery on maternal and neonatal outcomes

Investigating the effect of team collaboration based on an evidence-based collaborative model in the management of normal labor and delivery on maternal and neonatal outcomes: a randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181214041963N5
Enrollment
204
Registered
2024-04-21
Start date
2024-04-27
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Team collaboration based on an evidence-based collaborative model in the management of normal labor and delivery.

Interventions

Intervention 1: Intervention group: In each stage of labor, delivery care is provided based on the decision and cooperation of the team members regarding the conditions of the progress of labor, the c

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Consent to participate in the research Gravid 1to3 From the time of admission for delivery to 6 cm dilatation Mother's age between 15 and 45 years singleton pregnancy live fetus Gestational age 37 to 42 weeks (based on the first day of the last menstrual period or ultrasound of the first trimester) Cephalic presentation Normal fetal heart rate (110-160)

Exclusion criteria

Exclusion criteria: History of any incision on the uterus Indication for caesarean section (fetal distress, prolapse of the umbilical cord, diagnosis of absolute pelvic stenosis by the doctor) Known medical diseases based on the patient's file (including history or current suffering from any systemic diseases such as diabetes, high blood pressure, heart, kidney, nervous, liver, digestive, respiratory, thyroid disease) Mother's psychological problems in the last 6 months Having an abnormal fetus or intrauterine growth restriction High-risk pregnancy (pre-eclampsia, placenta previa, Placental abruption, chorioamnionitis, placenta accreta, placenta previa)

Design outcomes

Primary

MeasureTime frame
The length of labor stages. Timepoint: During the study. Method of measurement: Partograph.;Type of delivery. Timepoint: After the study. Method of measurement: Questionnaire.;Postpartum bleeding. Timepoint: During the study. Method of measurement: Check list.;Genital lacerations. Timepoint: During the study. Method of measurement: Check list.;Apgar first and fifth minutes. Timepoint: After the intervention. Method of measurement: Check list.;Hospitalization in the neonatal intensive care unit. Timepoint: After the intervention. Method of measurement: Check list.;Satisfaction with childbirth. Timepoint: After the study. Method of measurement: Mackey questionnaire.;Childbirth Experience. Timepoint: After the study. Method of measurement: Childbirth Experience Questionnaire.;Admission to the neonatal unit. Timepoint: After the study. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Early breastfeeding. Timepoint: During the study. Method of measurement: Check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina Iravani

Ahvaz University of Medical Sciences

Minairavani2004@gmail.com+98 61 3311 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026